Boundless Bio (BOLD) Earnings Analysis
Boundless Bio (BOLD) has no confirmed upcoming earnings date. Last quarter (2026-05-08) it missed with EPS -0.6 USD vs -0.51 USD est (-17.6%). It has beaten estimates in 2/5 recent quarters (40%). Trailing P/E -1.01.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does BOLD next report earnings?
No confirmed upcoming earnings date is currently scheduled for BOLD. This page updates as the calendar is published.
BOLD earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-08 | -0.6 USD | -0.51 USD | -17.6% | Miss |
| 2026-03-09 | -0.58 USD | -0.44 USD | -31.8% | Miss |
| 2025-05-09 | -0.71 USD | -0.68 USD | -4.4% | Miss |
| 2024-11-07 | -0.74 USD | -0.76 USD | +2.6% | Beat |
| 2024-08-12 | -0.77 USD | -0.78 USD | +1.3% | Beat |
Beat rate: 2/5 (40%) over reported quarters with consensus data.
BOLD valuation and analyst view
| Trailing P/E | -1.01 |
|---|---|
| Trailing EPS | -2.49895 USD |
| Price / book | 0.65 |
| Dividend yield | 0.00% |
| Market cap | 0.06B |
| Analyst consensus | Hold (6 buy / 13 hold / 1 sell) |
Related research pages
Frequently asked questions
When is Boundless Bio (BOLD)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for BOLD. This page updates as the calendar is published.
Did BOLD beat earnings last quarter?
In its 2026-05-08 report, BOLD posted EPS of -0.6 USD versus a -0.51 USD estimate — a miss of 17.6%.
What is BOLD's earnings track record?
Over the last 5 reported quarters with consensus data, BOLD beat estimates 2 times (40%).
What is BOLD's current P/E ratio and EPS?
BOLD trades at a trailing P/E of -1.01 on trailing EPS of -2.498951220600705 USD.
What do analysts rate BOLD?
Analyst consensus is "Hold" across 20 ratings (0 strong buy, 6 buy, 13 hold, 1 sell, 0 strong sell).